Clinical trial · Observational
Progression of Hematopoietic Diseases in Shanghai, China
Analysis of Disease Progression for Aplastic Anemia, Myelodysplastic Syndrome, Acute Myeloid Leukemia and Benzene Poisoning in Shanghai, China.
NCT00365014CI-TRIAL-00011452completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to identify and characterize blood diseases presenting at Shanghai hospitals and to compare them with respect to clinical presentation, phenotype, molecular characteristics, benzene or other exposures and genetic susceptibility.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Hematologic Diseases | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (1)
- label
- Blood disease patients
- description
- People with blood diseases presenting at Shanghai hospitals
Primary outcomes (1)
- measure
- blood diseases presenting at Shanghai hospitals
- timeFrame
- hospital stay
- description
- characterization of people with blood diseases presenting at Shanghai hospitals
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: Men and women 18 years or older Diagnosis of hematologic abnormality Exclusion Criteria: Children Non hematologic diseases
References
Publications (0)
Data not yet available
No reference posted for this study.